$704.90
28.864.27%
Last update: Nov 9, 2:24 PM
IDEXX Laboratories Inc
IDXXNASDAQ
IDEXX Laboratories (IDXX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
IDEXX Laboratories (IDXX) last issued guidance on November 2, 2026 for fiscal year 2026. The company guided earnings per share in the range of $14.96 - $15.16, compared to a consensus EPS estimate of $14.86. IDEXX Laboratories also guided revenue in the range of $4.74B - $4.77B for the period.
Compared to prior guidance, IDEXX Laboratories raised its EPS outlook from a previous range of $14.69 - $14.94. On the revenue side, the company maintained its revenue forecast from a prior range of $4.7B - $4.75B.
IDEXX Laboratories has issued 17 guidance updates between February 6, 2023 and November 2, 2026. During this period, the company raised its outlook 8 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $3.71 | $3.94 | $3.41 | $2.93 |
| Actual | $4.01 | $4.27 | $3.47 | $3.08 |
| Surprise | +8.09% | +8.38% | +1.76% | +5.12% |
| Revenue | ||||
| Estimate | $1.19B | $1.20B | $1.11B | $1.07B |
| Actual | $1.21B | $1.22B | $1.14B | $1.09B |
| Surprise | +1.85% | +1.43% | +2.69% | +1.85% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $3.84 | $3.97 | $4.60 | $4.36 |
| Revenue | ||||
| Consensus | $1.23B | $1.23B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 2, 2026 | $4.01 | $3.71 | 8.09 % |
| Q2 | Aug 4, 2026 | $4.27 | $3.94 | 8.38 % |
| Q1 | May 5, 2026 | $3.47 | $3.41 | 1.76 % |
| Q4 | Feb 2, 2026 | $3.08 | $2.93 | 5.12 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 2, 2026 | $1.21B | $1.19B | 1.85 % |
| Q2 | Aug 4, 2026 | $1.22B | $1.20B | 1.43 % |
| Q1 | May 5, 2026 | $1.14B | $1.11B | 2.69 % |
| Q4 | Feb 2, 2026 | $1.09B | $1.07B | 1.85 % |
